The challenges and opportunities of multiple sclerosis care in Latin America [0.03%]
拉美地区多发性硬化症治疗的挑战与机遇
Daniel Ontaneda,Jorge Correale
Daniel Ontaneda
Cognitive and neuropsychiatric disorders among MS patients from Latin America [0.03%]
拉丁美洲多发性硬化患者的认知和神经精神障碍
Sandra Vanotti,Fernando J Caceres
Sandra Vanotti
Cognitive and neuropsychiatric disorders in patients with multiple sclerosis have been extensively documented. The focus of this review will be on cognitive and neuropsychiatric disorders in multiple sclerosis patients from Latin America, i...
Y D Fragoso,F G Elso,A Carrá
Y D Fragoso
Improvement of multiple sclerosis (MS) diagnoses leads to earlier and correct disease management. The differential diagnostic workup for MS comprises a large variety of medical conditions. There are general guidelines and criteria for diagn...
Testing patient-reported outcome measurement equivalence in multinational clinical trials: An exemplar using the 12-item Multiple Sclerosis Walking Scale [0.03%]
多国临床试验中患者报告结果测量等价性检验：利用12项多发性硬化行走量表进行演示
Hussein Dib,Yusuf Tamam,Murat Terzi et al.
Hussein Dib et al.
Background: Although multinational clinical trials frequently use patient-reported outcomes to measure efficacy, measurement equivalence across cultures and languages, a scientific requirement, is rarely tested. Clinicall...
Effects of vitamin D3 in clinically isolated syndrome and healthy control participants: A double-blind randomised controlled trial [0.03%]
维生素D3对临床孤立综合征和健康对照参与者的影响：一项双盲随机对照试验
Karen O&#x;Connell,Jamal Sulaimani,Sharee A Basdeo et al.
Karen O&#x;Connell et al.
Background: Lowserum vitamin D levels are associated with susceptibility to, and severity of, multiple sclerosis. High dose vitamin D has been proposed as a potential immunomodulator in multiple sclerosis. ...
Healthcare expenditure of multiple sclerosis patients in 2013: A nationwide study based on French health administrative databases [0.03%]
2013年法国多发性硬化症患者的卫生保健支出：基于法国健康行政数据库的全国性研究
Delphine Lefeuvre,Jérémie Rudant,Stéphanie Foulon et al.
Delphine Lefeuvre et al.
Background: Little is known about expenditure items of multiple sclerosis (MS) patients over recent years in France. Objective: To desc...
Quantitative characterization of optic nerve atrophy in patients with multiple sclerosis [0.03%]
多发性硬化患者的视神经萎缩的定量特征分析
Robert L Harrigan,Alex K Smith,Bailey Lyttle et al.
Robert L Harrigan et al.
Background: Optic neuritis (ON) is one of the most common presentations of multiple sclerosis (MS). Magnetic resonance imaging (MRI) of the optic nerves is challenging because of retrobulbar motion, orbital fat and suscep...
Serum retinol levels are associated with brain volume loss in patients with multiple sclerosis [0.03%]
血清视黄醇水平与多发性硬化患者脑容量丢失有关
H Yokote,T Kamata,S Toru et al.
H Yokote et al.
Background: Although predicting future brain volume loss (BVL) in patients with multiple sclerosis (MS) is important, studies have shown only a few biomarkers that can predict BVL. ...
Which symptoms contribute the most to patients' perception of health in multiple sclerosis? [0.03%]
哪些症状最影响多发性硬化患者的健康感知？
Rivka Green,Gary Cutter,Michael Friendly et al.
Rivka Green et al.
Background: Multiple sclerosis is a polysymptomatic disease. Little is known about relative contributions of the different multiple sclerosis symptoms to self-perception of health. ...
Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 24-month follow-up [0.03%]
在临床实践中的疗效和停药比较：二甲基呋喃酸酯与芬戈莫德两年的随访结果分析
Carrie M Hersh,Thomas E Love,Anasua Bandyopadhyay et al.
Carrie M Hersh et al.
Background: Dimethyl fumarate and fingolimod are oral disease-modifying therapies approved to treat relapsing multiple sclerosis. Prior observational studies and our previous 12-month investigation showed comparable clini...